Silverarc Capital Management, LLC Nkarta, Inc. Transaction History

Silverarc Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$12.27 - $18.39 $3.09 Million - $4.63 Million	251,614 Added 227.16%	362,377 $4.77 Million
Q2 2022 Jul 25, 2022	BUY	$7.77 - $19.44 $860,628 - $2.15 Million	110,763 New	110,763 $1.37 Million
Q1 2021 May 18, 2021	SELL	$31.33 - $59.61 $469,950 - $894,150	-15,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.03 - $75.62 $405,450 - $1.13 Million	15,000 New	15,000 $922,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $119M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.